These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23499601)

  • 21. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Kwong JC; Buchan SA; Chung H; Campitelli MA; Schwartz KL; Crowcroft NS; Jackson ML; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Simor A; Smieja M; Zahariadis G; Campigotto A; Gubbay JB
    Vaccine; 2019 Jul; 37(31):4392-4400. PubMed ID: 31221563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design.
    Kimiya T; Shinjoh M; Anzo M; Takahashi H; Sekiguchi S; Sugaya N; Takahashi T
    Eur J Pediatr; 2018 Jul; 177(7):1009-1017. PubMed ID: 29680993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season.
    Kavanagh K; Robertson C; McMenamin J
    Vaccine; 2013 Sep; 31(41):4556-63. PubMed ID: 23933371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.
    Feldstein LR; Ferdinands JM; Self WH; Randolph AG; Aboodi M; Baughman AH; Brown SM; Exline MC; Clark Files D; Gibbs K; Ginde AA; Gong MN; Grijalva CG; Halasa N; Khan A; Lindsell CJ; Newhams M; Peltan ID; Prekker ME; Rice TW; Shapiro NI; Steingrub J; Talbot HK; Halloran ME; Patel M
    J Infect Dis; 2021 Dec; 224(12):2035-2042. PubMed ID: 34013330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?
    Donahue JG; Kieke BA; Szilagy PG; Blumkin AK; Hilgemann D; Flanders WD; Shay DK; Meece J; Gallivan S; Treanor J; Belongia EA
    Vaccine; 2014 Nov; 32(48):6440-4. PubMed ID: 25284810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza vaccine effectiveness in primary school children in Japan: a prospective cohort study using rapid diagnostic test results.
    Yamaguchi S; Ohfuji S; Hirota Y
    J Infect Chemother; 2010 Dec; 16(6):407-13. PubMed ID: 20490595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in estimating influenza vaccine effectiveness.
    Ainslie KEC; Haber M; Orenstein WA
    Expert Rev Vaccines; 2019 Jun; 18(6):615-628. PubMed ID: 31116070
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.
    Ferdinands JM; Fry AM; Reynolds S; Petrie J; Flannery B; Jackson ML; Belongia EA
    Clin Infect Dis; 2017 Mar; 64(5):544-550. PubMed ID: 28039340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of trivalent flu vaccine in healthy young children.
    Blyth CC; Jacoby P; Effler PV; Kelly H; Smith DW; Robins C; Willis GA; Levy A; Keil AD; Richmond PC;
    Pediatrics; 2014 May; 133(5):e1218-25. PubMed ID: 24753525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of Vaccine Direct Effects Under the Test-Negative Design.
    Lewnard JA; Tedijanto C; Cowling BJ; Lipsitch M
    Am J Epidemiol; 2018 Dec; 187(12):2686-2697. PubMed ID: 30099505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.
    Jackson ML; Jackson LA; Kieke B; McClure D; Gaglani M; Murthy K; Malosh R; Monto A; Zimmerman RK; Foppa IM; Flannery B; Thompson MG
    Vaccine; 2015 Sep; 33(39):5181-7. PubMed ID: 26271827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
    Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
    PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
    Bartoszko JJ; McNamara IF; Aras OAZ; Hylton DA; Zhang YB; Malhotra D; Hyett SL; Morassut RE; Rudziak P; Loeb M
    Vaccine; 2018 Jun; 36(24):3434-3444. PubMed ID: 29724509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies.
    Jackson ML
    Vaccine X; 2019 Apr; 1():100003. PubMed ID: 33826685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).
    Feldstein LR; Self WH; Ferdinands JM; Randolph AG; Aboodi M; Baughman AH; Brown SM; Exline MC; Files DC; Gibbs K; Ginde AA; Gong MN; Grijalva CG; Halasa N; Khan A; Lindsell CJ; Newhams M; Peltan ID; Prekker ME; Rice TW; Shapiro NI; Steingrub J; Talbot HK; Halloran ME; Patel M;
    Clin Infect Dis; 2021 May; 72(9):1669-1675. PubMed ID: 32974644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
    Talbot HK; Nian H; Chen Q; Zhu Y; Edwards KM; Griffin MR
    Vaccine; 2016 Apr; 34(15):1806-9. PubMed ID: 26930368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.